(Q35680147)

9 August 2017

1 reference

title

Electrical cardioversion of atrial fibrillation (English)

1 reference

9 August 2017

1 reference

1 reference

Jose A Joglar

1

1 reference

9 August 2017

Robert C Kowal

series ordinal

2

1 reference

9 August 2017

publication date

1 February 2004

1 reference

9 August 2017

1 reference

9 August 2017

volume

22

1 reference

9 August 2017

issue

1

1 reference

9 August 2017

page(s)

101-111

1 reference

Prevalence, age distribution, and gender of patients with atrial fibrillation. Analysis and implications

9 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2803%2900119-X

7 January 2021

A comparison of rate control and rhythm control in patients with atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2803%2900119-X

7 January 2021

Increasing fibrillation duration enhances relative asymmetrical biphasic versus monophasic defibrillator waveform efficacy

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2803%2900119-X

7 January 2021

Improved internal defibrillation efficacy with a biphasic waveform

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2803%2900119-X

7 January 2021

Comparison of biphasic and monophasic shocks for defibrillation using a nonthoracotomy system.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2803%2900119-X

7 January 2021

Automated external defibrillators: technical considerations and clinical promise

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2803%2900119-X

7 January 2021

Prospective assessment of the minimum energy needed for external electrical cardioversion of atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2803%2900119-X

7 January 2021

Initial energy for elective external cardioversion of persistent atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2803%2900119-X

7 January 2021

A comparison of 50-J versus 100-J shocks for direct-current cardioversion of atrial flutter

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2803%2900119-X

7 January 2021

Transthoracic cardioversion of atrial fibrillation: comparison of rectilinear biphasic versus damped sine wave monophasic shocks

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2803%2900119-X

7 January 2021

Biphasic versus monophasic shock waveform for conversion of atrial fibrillation: the results of an international randomized, double-blind multicenter trial

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2803%2900119-X

7 January 2021

Predictors of unsuccessful electrical cardioversion in atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2803%2900119-X

7 January 2021

Energy, current, and success in defibrillation and cardioversion: clinical studies using an automated impedance-based method of energy adjustment

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2803%2900119-X

7 January 2021

Effectiveness of direct current defibrillation: role of paddle electrode size: II

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2803%2900119-X

7 January 2021

Myocardial necrosis from direct current countershock. Effect of paddle electrode size and time interval between discharges

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2803%2900119-X

7 January 2021

Transthoracic cardioversion of atrial fibrillation and flutter: standard techniques and new advances

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2803%2900119-X

7 January 2021

External cardioversion of atrial fibrillation: role of paddle position on technical efficacy and energy requirements

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2803%2900119-X

7 January 2021

Anterior-posterior versus anterior-lateral electrode positions for external cardioversion of atrial fibrillation: a randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2803%2900119-X

7 January 2021

Elective Cardioversion: Influence of Paddle-Electrode Location and Size on Success Rates and Energy Requirements

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2803%2900119-X

7 January 2021

Transthoracic defibrillation: importance of avoiding electrode placement directly on the female breast

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2803%2900119-X

7 January 2021

ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation: executive summary. A Report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Co

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2803%2900119-X

7 January 2021

Influence of ventilation phase on transthoracic impedance and defibrillation effectiveness

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2803%2900119-X

7 January 2021

Transthoracic resistance in human defibrillation. Influence of body weight, chest size, serial shocks, paddle size and paddle contact pressure

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2803%2900119-X

7 January 2021

Active compression cardioversion for refractory atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2803%2900119-X

7 January 2021

Transthoracic defibrillation: Effect of sternotomy on chest impedance

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2803%2900119-X

7 January 2021

Titration of intravenous anesthetics for cardioversion: a comparison of propofol, methohexital, and midazolam.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2803%2900119-X

7 January 2021

The use of quinidine in cardioversion.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2803%2900119-X

7 January 2021

Higher energy synchronized external direct current cardioversion for refractory atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2803%2900119-X

7 January 2021

Facilitating transthoracic cardioversion of atrial fibrillation with ibutilide pretreatment.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2803%2900119-X

7 January 2021

Oral amiodarone increases the efficacy of direct-current cardioversion in restoration of sinus rhythm in patients with chronic atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2803%2900119-X

7 January 2021

Immediate reinitiation of atrial fibrillation after electrical cardioversion predicts subsequent pharmacologic and electrical conversion to sinus rhythm and amiodarone

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2803%2900119-X

7 January 2021

Effects of oral propafenone administration before electrical cardioversion of chronic atrial fibrillation: a placebo-controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2803%2900119-X

7 January 2021

Pretreatment with verapamil in patients with persistent or chronic atrial fibrillation who underwent electrical cardioversion

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2803%2900119-X

7 January 2021

Use of irbesartan to maintain sinus rhythm in patients with long-lasting persistent atrial fibrillation: a prospective and randomized study.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2803%2900119-X

7 January 2021

Transvenous atrial defibrillation--techniques and clinical applications.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2803%2900119-X

7 January 2021

Transvenous low energy internal cardioversion for atrial fibrillation: a review of clinical applications and future developments

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2803%2900119-X

7 January 2021

Predictors of atrial defibrillation threshold in internal cardioversion

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2803%2900119-X

7 January 2021

Low-energy internal cardioversion in patients with long-lasting atrial fibrillation refractory to external electrical cardioversion: results and long-term follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2803%2900119-X

7 January 2021

Internal cardioversion: a worthwhile alternative after failed external cardioversion in obese patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2803%2900119-X

7 January 2021

Successful external cardioversion of atrial fibrillation in patients referred to an electrophysiologist for internal cardioversion

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2803%2900119-X

7 January 2021

Role of prophylactic anticoagulation for direct current cardioversion in patients with atrial fibrillation or atrial flutter

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2803%2900119-X

7 January 2021

Use of transesophageal echocardiography to guide cardioversion in patients with atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2803%2900119-X

7 January 2021

The efficacy of anticoagulant therapy in preventing embolism related to D.C. electrical conversion of atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2803%2900119-X

7 January 2021

Thromboembolism in chronic atrial flutter: is the risk underestimated?

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2803%2900119-X

7 January 2021

Is atrial flutter a risk factor for stroke?

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2803%2900119-X

7 January 2021

Enzyme release after elective cardioversion

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2803%2900119-X

7 January 2021

Time course of troponin I, myoglobulin, and cardiac enzyme release after electrical cardioversion

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2803%2900119-X

7 January 2021

Plasma levels of troponin T after electrical cardioversion of atrial fibrillation and flutter

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2803%2900119-X

7 January 2021

Cardiac troponin I levels are normal or minimally elevated after transthoracic cardioversion

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2803%2900119-X

7 January 2021

Incidence and clinical significance of ST segment elevation after electrical cardioversion of atrial fibrillation and atrial flutter

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2803%2900119-X

7 January 2021

Electrical-induced sustained myocardial depolarization as a possible cause for transient ST elevation post-DC elective cardioversion

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2803%2900119-X

7 January 2021

Nature and determinants of skin "burns" after transthoracic cardioversion

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2803%2900119-X

7 January 2021

The optimal technique for electrical cardioversion of atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2803%2900119-X

7 January 2021

10.1016/S0733-8651(03)00119-X

Identifiers

DOI

1 reference

9 August 2017

1 reference